Anna Steward

Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies

Updated safety results from phase 3 lecanemab study in early Alzheimer’s disease

sTREM2 is associated with amyloid‐related p‐tau increases and glucose hypermetabolism in Alzheimer's disease

Earlier Alzheimer’s disease onset is associated with tau pathology in brain hub regions and facilitated tau spreading